LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
bioRxiv (2021) - Comments
doi: 10.1101/2021.05.01.21256470 

Zelalem Temesgen, Charles D. Burger, Jason Baker, Christopher Polk, Claudia Libertin, Colleen Kelley, Vincent C. Marconi, Robert Orenstein, Cameron Durrant, Dale Chappell, Omar Ahmed, Gabrielle Chappell, Andrew D. Badley